3646 results for «687»
3646 results
Novelty in PCI
17 May 2023 – From EuroPCR 2023
Obtain a deep understanding of different scenarios that illustrate PCI through a series of selected cases. To name a few: new stent positionning assistance system in stent saving PCI; Multiple stent implantations in a patient with diffuse disease using SPAS device; Cost-effective but productive technique to...
Valve-in-valve procedures - Part 1
18 May 2023 – From EuroPCR 2023
Discover the innovative solutions offered by valve-in-valve procedures in this session: witness the successful application of this technique in a patient with heparin-induced thrombocytopenia, explore a captivating case series showcasing valve-in-valve TAVI in failed Perceval bioprostheses, delve into the complexities of TAVR in SAVR in IIIb type...
PCI complications - Part 2
17 May 2023 – From EuroPCR 2023
Discover an exciting range of complexities in PCI and explore the strategies implemented by your colleagues to overcome the challenges presented by this intriguing case series. Begin your journey with a captivating first case, featuring stent loss in a partially ostial right coronary artery. Join them...
STEMI: how to treat the thrombus
18 May 2023 – From EuroPCR 2023
Consult this session to gain insights into the treatment of thrombus in STEMI cases: discover a primary angioplasty trick for managing a thrombus-laden RCA, explore the effectiveness of intracoronary thrombolysis and aspiration thrombectomy, uncover a unique approach to addressing left main stem complications with a "less...
Pivotal study on the ShortCut transcatheter aortic valve leaflet splitting device
16 May 2024
Coronary obstruction is a major concern in patients undergoing TAVI for degenerated bioprostheses (valve-in-valve [ViV]) and is associated with a 30-day mortality rate of around 50%.1 While several transcatheter techniques to lacerate bioprosthetic valve leaflets prior to TAVI placement (such as BASILICA) have been described, they are...
GLORIOUS - Efficacy of restrictive versus liberal oxygenation or Exenatide in patients undergoing coronary artery bypass grafting or aortic valve replacement – a randomised clinical trial
21 Nov 2024
Edoardo Zancanaro provides his take on the GLORIOUS trial presented by Sebastian Wiberg at AHA 2024 in Chicago.
Author
